Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate DarioHealth Corp. before investing.

In this article, we go over a few key elements for understanding DarioHealth Corp.’s stock price such as:

• DarioHealth Corp.’s current stock price and volume
• Why DarioHealth Corp.’s stock price changed recently
• Upgrades and downgrades for DRIO from analysts
• DRIO’s stock price momentum as measured by its relative strength

About DarioHealth Corp. (DRIO)

Before we jump into DarioHealth Corp.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Want to learn more about DarioHealth Corp.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about DarioHealth Corp..

DarioHealth Corp.’s Stock Price as of Market Close

As of August 21, 2026, 4:00 PM, CST, DarioHealth Corp.’s stock price was $7.490.

DarioHealth Corp. is up 4.46% from its previous closing price of $7.170.

During the last market session, DarioHealth Corp.’s stock traded between $7.100 and $8.060. Currently, there are approximately 9.34 million shares outstanding for DarioHealth Corp..

DarioHealth Corp.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

DarioHealth Corp. Stock Price History

DarioHealth Corp.’s (DRIO) price is currently up 3.03% so far this month.

During the month of August, DarioHealth Corp.’s stock price has reached a high of $8.200 and a low of $6.190.

Over the last year, DarioHealth Corp. has hit prices as high as $17.744 and as low as $5.845. Year to date, DarioHealth Corp.’s stock is down 34.18%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused DarioHealth Corp. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 20, 2026, there was 1 analyst who downgraded DarioHealth Corp.’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate DarioHealth Corp.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on DarioHealth Corp.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

DarioHealth Corp.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about DarioHealth Corp. (DRIO) by visiting AAII Stock Evaluator.

Relative Price Strength of DarioHealth Corp.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 20, 2026, DarioHealth Corp. has a weighted four-quarter relative price strength of -4.08%, which translates to a Momentum Score of 36 and is considered to be Weak.

Want to learn more about how DarioHealth Corp. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

DarioHealth Corp. Stock Price: Bottom Line

As of August 21, 2026, DarioHealth Corp.’s stock price is $7.490, which is up 4.46% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like DarioHealth Corp. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.